{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:53:06Z","timestamp":1793465586190,"version":"4.5.0"},"reference-count":74,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: This manuscript provides an overview of liver carcinogenesis in murine models of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA).  Objective: A review through MEDLINE and EMBASE was performed to assess articles until August 2022.  Methods: Search was conducted of the entire electronic databases and the keywords used was HCC, CCA, carcinogenesis, animal models and liver. Articles exclusion was based on the lack of close relation to the subject. Carcinogenesis models of HCC include HCC induced by senescence in transgenic animals, HCC diet-induced, HCC induced by chemotoxicagents, xenograft, oncogenes, and HCC in transgenic animals inoculated with B and C virus. The models of CCA include the use of dimethylnitrosamine (DMN), diethylnitrosamine (DEN), thioacetamide (TAA), and carbon tetrachloride (CCl4). CCA murine models may also be induced by: CCA cells, genetic manipulation, Smad4, PTEN and p53 knockout, xenograft, and DEN-left median bile duct ligation.  Results: In this review, we described different murine models of carcinogenesis that reproduce the key points for HCC and CCA genesis allowing a better understanding of its genetic, physiopathological, and environmental abnormalities.  Conclusion: Each model has its advantages, disadvantages, similarities, and differences with the corresponding human disease and should be chosen according to the specificity of the study. Ultimately, those models can also be used for testing new anticancer therapeutic approaches.<\/jats:p>","DOI":"10.1590\/s0004-2803.230302023-58","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:35:00Z","timestamp":1695641700000},"page":"383-392","source":"Crossref","is-referenced-by-count":8,"title":["PRECLINICAL MODELS OF LIVER C\u00c2NCER"],"prefix":"10.1590","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1924-3208","authenticated-orcid":false,"given":"Fl\u00e1vio Henrique Ferreira","family":"GALV\u00c3O","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Laborat\u00f3rio de Transplante e Cirurgia do F\u00edgado (LIM-37),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1489-5799","authenticated-orcid":false,"given":"Maria Clara Camargo","family":"TRALDI","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Laborat\u00f3rio de Transplante e Cirurgia do F\u00edgado (LIM-37),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-5420","authenticated-orcid":false,"given":"Renata Sandres Souza","family":"ARA\u00daJO","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Gastroenterologia Cl\u00ednica e Experimental (LIM-07),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-1920","authenticated-orcid":false,"given":"Jose Tadeu","family":"STEFANO","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Laborat\u00f3rio de Gastroenterologia Cl\u00ednica e Experimental (LIM-07),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-7168","authenticated-orcid":false,"given":"Luiz Augusto Carneiro","family":"D\u2019ALBUQUERQUE","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Laborat\u00f3rio de Transplante e Cirurgia do F\u00edgado (LIM-37),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-417X","authenticated-orcid":false,"given":"Claudia P","family":"OLIVEIRA","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Laborat\u00f3rio de Gastroenterologia Cl\u00ednica e Experimental (LIM-07),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jhep.2014.11.015","article-title":"Reports from the International Liver Cancer Association (ILCA) congress 2014","volume":"62","author":"Nault JC","year":"2015","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag HB","year":"2011","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner A","year":"2018","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet JM","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti GA","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2018.06.009","article-title":"Mutational landscape of a chemically-induced mouse model of liver cancer","volume":"69","author":"Connor F","year":"2018","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/HMER.S137209","article-title":"Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment","volume":"10","author":"Gunaydin M","year":"2018","journal-title":"Hepat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/cancers13153651","article-title":"Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective","volume":"13","author":"Blidisel A","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher\u2019s guide to preclinical mouse NASH models","volume":"4","author":"Gallage S","year":"2022","journal-title":"Nat Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12864-020-06869-4","article-title":"Comparative RNA-Seq transcriptome analyses reveal dynamic time-dependent effects of","volume":"21","author":"Nia AM","year":"2020","journal-title":"BMC Genomics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fonc.2018.00268","article-title":"Transgenic Mouse Models in Cancer Research","volume":"8","author":"Lampreht Tratar U","year":"2018","journal-title":"Front Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10599","article-title":"Senescence surveillance of pre-malignant hepatocytes limits liver cancer development","volume":"479","author":"Kang TW","year":"2011","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.201009094","article-title":"Four faces of cellular senescence","volume":"192","author":"Rodier F","year":"2011","journal-title":"J Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-05-4608","article-title":"Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression","volume":"66","author":"Farazi PA","year":"2006","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bbadis.2018.08.009","article-title":"Animal models for hepatocellular carcinoma","volume":"1865","author":"Zhang HE","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jss.2007.12.748","article-title":"Mouse model of diethylnitrosamine-induced gastric cancer","volume":"148","author":"Binato M","year":"2008","journal-title":"J Surg Res"},{"key":"ref17","first-page":"5021","article-title":"Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma","volume":"63","author":"Farazi PA","year":"2003","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0023677215570086","article-title":"Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice","volume":"49","author":"Tolba R","year":"2015","journal-title":"Lab Anim"},{"key":"ref19","first-page":"274","article-title":"Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mic","volume":"7","author":"Puatanachokchai R","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/carcin\/bgq226","article-title":"Tumor formation in liver of conditional \u03b2-catenin-deficient mice exposed to a diethylnitrosamine\/ phenobarbital tumor promotion regimen","volume":"32","author":"Rignall B","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjp.2008.338","article-title":"The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation","volume":"155","author":"Campo GM","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2005.01.034","article-title":"A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis","volume":"43","author":"Domenicali M","year":"2005","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jat.892","article-title":"Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride","volume":"23","author":"Muriel P","year":"2003","journal-title":"J Appl Toxicol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark KR","year":"2009","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0300-483X(01)00429-2","article-title":"Carbon tetrachloride-induced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: role of antioxidants","volume":"165","author":"Sheweita SA","year":"2001","journal-title":"Toxicology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/labinvest.2010.139","article-title":"Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity","volume":"90","author":"Yang MC","year":"2010","journal-title":"Lab Invest"},{"key":"ref27","first-page":"4594","article-title":"Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans","volume":"63","author":"McGlynn KA","year":"2003","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/toxsci\/kfr087","article-title":"Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice","volume":"122","author":"Woo LL","year":"2011","journal-title":"Toxicol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2008.07.024","article-title":"A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma","volume":"49","author":"de Lima VM","year":"2008","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1242\/jcs.01016","article-title":"Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation","volume":"117","author":"Zhong B","year":"2004","journal-title":"J Cell Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.23880","article-title":"Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet","volume":"52","author":"Guest I","year":"2010","journal-title":"Hepatology"},{"key":"ref32","first-page":"4","article-title":"[18F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib","volume":"4","author":"Costa FGB","year":"2018","journal-title":"Hepatoma Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jceh.2014.12.010","article-title":"Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet","volume":"5","author":"Hamzawy M","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour A","year":"2016","journal-title":"J Hepatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida T","year":"2018","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrc2192","article-title":"Maximizing mouse cancer models","volume":"7","author":"Frese KK","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000082090","article-title":"Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver","volume":"48","author":"Koo JS","year":"2005","journal-title":"Intervirology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1440-1746.2003.02902.x","article-title":"Hepatocellular carcinoma in a hepatitis B \u2018x\u2019 transgenic mouse model: A sequential pathological evaluation","volume":"18","author":"Lakhtakia R","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3748\/wjg.v9.i1.112","article-title":"Expression of hepatitis B virus X protein in transgenic mice","volume":"9","author":"Xiong J","year":"2003","journal-title":"World J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1099\/vir.0.80969-0","article-title":"Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2","volume":"86","author":"Naas T","year":"2005","journal-title":"J Gen Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.20621","article-title":"Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis","volume":"41","author":"Kamegaya Y","year":"2005","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2007.05.006","article-title":"The role of NF-kappaB in hepatocarcinogenesis: promoter or suppressor?","volume":"47","author":"Seki E","year":"2007","journal-title":"J Hepatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/0008-5472.CAN-03-2123","article-title":"Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations","volume":"64","author":"Harada N","year":"2004","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jhep.2005.05.018","article-title":"Oncogenic role of the frizzled-7\/beta-catenin pathway in hepatocellular carcinoma","volume":"43","author":"Merle P","year":"2005","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1111\/j.1440-1746.2006.04665.x","article-title":"Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice","volume":"22","author":"Watanabe S","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1699-0463.1969.tb04520.x","article-title":"Heterotransplantation of a human malignant tumour to \u201cNude\u201d mice","volume":"77","author":"Rygaard J","year":"1969","journal-title":"Acta Pathol Microbiol Scand"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI20513","article-title":"Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas","volume":"113","author":"Horie Y","year":"2004","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","article-title":"Experimental models of hepatocellular carcinoma","volume":"48","author":"Newell P","year":"2008","journal-title":"J Hepatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7","article-title":"Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues","volume":"66","author":"Sun FX","year":"1996","journal-title":"Int J Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-05-2568","article-title":"Xenografts of human hepatocellular carcinoma: a useful model for testing drugs","volume":"12","author":"Huynh H","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref51","first-page":"557","article-title":"ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model","volume":"2","author":"Matsuo M","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1478-3231.2008.01670.x","article-title":"Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis","volume":"28","author":"Kornek M","year":"2008","journal-title":"Liver Int"},{"key":"ref53","first-page":"2049","article-title":"Reducing the cost of screening novel agents using the hollow fibre assay","volume":"26","author":"Shnyder SD","year":"2006","journal-title":"Anticancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1593\/neo.10804","article-title":"Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy","volume":"12","author":"Tang TC","year":"2010","journal-title":"Neoplasia"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1078-0432.971.11.3","article-title":"50 years of preclinical anticancer drug screening: empirical to target-driven approaches","volume":"11","author":"Suggitt M","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/carcin\/bgg053","article-title":"Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato- and cholangiocarcinogenesis in mice by green tea infusion","volume":"24","author":"Umemura T","year":"2003","journal-title":"Carcinogenesis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbadis.2018.03.026","article-title":"Animal models of cholangiocarcinoma","volume":"1865","author":"Loeuillard E","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cancers12082308","article-title":"Evolution of the Experimental Models of Cholangiocarcinoma","volume":"12","author":"Massa A","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"700","DOI":"10.14218\/JCTH.2021.00374","article-title":"Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research","volume":"10","author":"Li M","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.dld.2011.06.014","article-title":"An oestrogen receptor \u03b2-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma","volume":"44","author":"Marzioni M","year":"2012","journal-title":"Dig Liver Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007082515548","article-title":"Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide","volume":"208","author":"Al-Bader A","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.22088","article-title":"A novel \u201cpatient-like\u201d model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines","volume":"47","author":"Sirica AE","year":"2008","journal-title":"Hepatology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2006.09.011","article-title":"Molecular pathology of biliary tract cancers","volume":"250","author":"Fava G","year":"2007","journal-title":"Cancer Lett"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.23729","article-title":"A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells","volume":"52","author":"Fingas CD","year":"2010","journal-title":"Hepatology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.23214","article-title":"Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2","volume":"50","author":"Blechacz BR","year":"2009","journal-title":"Hepatology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI27282","article-title":"Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice","volume":"116","author":"Xu X","year":"2006","journal-title":"J Clin Invest"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/hupa.2002.127444","article-title":"Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4\/Dpc4 in intrahepatic cholangiocarcinoma","volume":"33","author":"Kang YK","year":"2002","journal-title":"Hum Pathol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1158\/0008-5472.CAN-05-4609","article-title":"Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice","volume":"66","author":"Farazi PA","year":"2006","journal-title":"Cancer Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2559.1999.00705.x","article-title":"Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma","volume":"35","author":"Furubo S","year":"1999","journal-title":"Histopathology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2362.2000.00717.x","article-title":"New p53 mutations in hilar cholangiocarcinoma","volume":"30","author":"Tullo A","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"ref71","first-page":"1372","article-title":"Effect of cholecystokinin on human cholangiocarcinoma xenografted into nude mice","volume":"45","author":"Hudd C","year":"1985","journal-title":"Cancer Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/ijms12010385","article-title":"RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA","volume":"12","author":"Zhang K","year":"2011","journal-title":"Int J Mol Sci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/jhep.2000.8535","article-title":"Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells","volume":"32","author":"Yokomuro S","year":"2000","journal-title":"Hepatology"},{"key":"ref74","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.03.044","article-title":"A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.","volume":"141","author":"Yang H","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Modelos pr\u00e9-cl\u00ednicos de c\u00e2ncer hep\u00e1tico"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032023000300383&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:35:31Z","timestamp":1695641731000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032023000300383&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["S0004-28032023000300383"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.230302023-58","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}